In-vitro antibacterial and antibiofilm activities and in-silico analysis of a potent cyclic peptide from a novel Streptomyces sp. strain RG-5 against antibiotic-resistant and biofilm-forming pathogenic bacteria
- 30 October 2024
- journal article
- research article
- Published by Springer Nature in Archives of Microbiology
- Vol. 206 (11) , 1-16
Abstract
The proliferation of multidrug-resistant and biofilm-forming pathogenic bacteria poses a serious threat to public health. The limited effectiveness of current antibiotics motivates the search for new antibacterial compounds. In this study, a novel strain, RG-5, was isolated from desert soil. This strain exhibited potent antibacterial and antibiofilm properties against multidrug-resistant and biofilm-forming pathogenic bacteria. Through phenotypical characterizations, 16S rRNA gene sequence and phylogenetic analysis, the strain was identified as Streptomyces pratensis with 99.8% similarity. The active compound, RG5-1, was extracted, purified by reverse phase silica column HPLC, identified by ESI-MS spectrometry, and confirmed by 1H and 13C NMR analysis as 2,5-Piperazinedione, 3,6-bis(2-methylpropyl), belonging to cyclic peptides. This compound showed interesting minimum inhibitory concentrations (MICs) of 04 to 15 µg/mL and minimum biofilm inhibitory concentrations (MBICs 50%) of ½ MIC against the tested bacteria. Its molecular mechanism of action was elucidated through a molecular docking study against five drug-protein targets. The results demonstrated that the compound RG5-1 has a strong affinity and interaction patterns with glucosamine-6-phosphate synthase at − 6.0 kcal/mol compared to reference inhibitor (− 5.4 kcal/mol), medium with penicillin-binding protein 1a (− 6.1 kcal/mol), and LasR regulator protein of quorum sensing (− 5.4 kcal/mol), confirming its antibacterial and antibiofilm activities. The compound exhibited minimal toxicity and favorable physicochemical and pharmacological properties. This is the first report that describes its production from Streptomyces, its activities against biofilm-forming and multidrug-resistant bacteria, and its mechanism of action. These findings indicate that 2,5-piperazinedione, 3,6-bis(2-methylpropyl) has the potential to be a promising lead compound in the treatment of antibiotic-resistant and biofilm-forming pathogens. Graphical AbstractKeywords
This publication has 63 references indexed in Scilit:
- Antibacterial and antibiofilm properties of two cyclic dipeptides produced by a new desert Streptomyces sp. HG-17 strain against multidrug-resistant pathogenic bacteriaInternational Microbiology, 2024
- Biofilm inhibition/eradication: exploring strategies and confronting challenges in combatting biofilmArchives of Microbiology, 2024
- A New Saharan Strain of Streptomyces sp. GSB-11 Produces Maculosin and N-acetyltyramine Active Against Multidrug-Resistant Pathogenic BacteriaCurrent Microbiology, 2022
- Production of metabolites with antioxidant activity by Botryosphaeria dothidea in submerged fermentationBioprocess and Biosystems Engineering, 2019
- Small-Molecule Library Screening by Docking with PyRx2014
- Diketopiperazine constituents of marine Bacillus subtilisChemistry of Natural Compounds, 2009
- New PCR Primers for the Screening of NRPS and PKS-I Systems in Actinomycetes: Detection and Distribution of These Biosynthetic Gene Sequences in Major Taxonomic GroupsMicrobial Ecology, 2004
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Concordance of the Toxicity of Pharmaceuticals in Humans and in AnimalsRegulatory Toxicology and Pharmacology, 2000
- Pradimicin, A Novel Antifungal Agent1992